Coronavirus

Adults with atopic disease and asthma had a 38% decreased risk of COVID-19 infection, according to a new UK study.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

"COVID-somnia," defined as a group of chronic sleep disturbances, has made adequate rest elusive for millions, including health care first responders.

Among patients with obesity, prior weight loss achieved with bariatric surgery was associated with a 60% lower risk of severe COVID-19, suggests new research.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

The J&J booster shot given to health care workers in South Africa between mid-Nov and mid-Dec 2021 was highly effective against Omicron infection.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Pending endorsement from the CDC, adolescents can now get a booster dose of the Pfizer-BioNTech vaccine, as authorized by an amendment to the original FDA EUA for the vaccine.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

The CDC recommends against the J&J COVID-19 vaccine if Pfizer or Moderna mRNA shots are available while affirming that any COVID vaccine is better than none.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Pfizer reported today final results of the phase 2/3 EPIC-HR trial, findings that confirm the investigational drug's 89% efficacy against severe COVID-19 disease.

New research presented at EuroEcho 2021 may help explain why some patients with long COVID-19 experience persistent dyspnea even 1 year after recovery.

Influenza takes questions from key media outlets to rebut assertions by COVID-19 that Flu's heyday has come to an end. He replies to MSNBC, Fox News, CBS, & the Christian Science Monitor.

Referencing waning immunity of the 2-dose mRNA series and availability of the vaccine to youth in this age group for more than a year, FDA determined that benefits outweigh risks.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

New preliminary laboratory data showed 3 doses of the Pfizer-BioNTech COVID-19 vaccine neutralized the Omicron variant while 2 doses reduced neutralization titers.

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

Get a quick look at 12 of the many FDA-approved drugs in 2021 for conditions commonly seen in primary care.

Getting sick with COVID-19 is more worrisome to US adults than contracting the flu, the NFID found. How will that impact uptake of the flu shot this season?

Data from the CDC on boosters and US vaccination rates and from the Johns Hopkins COVID-19 interactive map on cases and deaths in the US and worldwide.

A J&J booster shot following a 2-dose regimen of the Pfizer vaccine produced a greater CD8+ T-cell response than a third Pfizer dose, according to preliminary data.